Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Expectoration | Research article

Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis

Authors: Gaspar Del Rio-Pertuz, Juan F. Gutiérrez, Abel J. Triana, Jorge L. Molinares, Andrea B. Robledo-Solano, José L. Meza, Orlando M. Ariza-Bolívar, Jorge Acosta-Reyes, Argenis Garavito, Diego Viasus, Jordi Carratalà

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Implementation of sputum Gram stain in the initial assessment of community-acquired pneumonia (CAP) patients is still controversial. We performed a systematic review and meta-analysis to investigate the usefulness of sputum Gram stain for defining the etiologic diagnosis of CAP in adult patients.

Methods

We systematically searched the Medline, Embase, Science Direct, Scopus and LILACS databases for full-text articles. Relevant studies were reviewed by at least three investigators who extracted the data, pooled them using a random effects model, and carried out quality assessment. For each bacterium (Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Gram-negative bacilli), pooled sensitivity, specificity, positive and negative likelihood ratios were reported.

Results

After a review of 3539 abstracts, 20 articles were included in the present meta-analysis. The studies included yielded 5619 patients with CAP. Pooled sensitivity and pooled specificity of sputum Gram stain were 0.59 (95% CI, 0.56–0.62) and 0.87 (95% CI, 0.86–0.89) respectively for S. pneumoniae, 0.78 (95% CI, 0.72–0.84) and 0.96 (95% CI, 0.94–0.97) for H. influenzae, 0.72 (95% CI, 0.53–0.87) and 0.97 (95% CI, 0.95–0.99) for S. aureus, and 0.64 (95% CI, 0.49–0.77) and 0.99 (95% CI, 0.97–0.99) for Gram-negative bacilli.

Conclusion

Sputum Gram stain test is sensitive and highly specific for identifying the main causative pathogens in adult patients with CAP.

Trial registration

This study has been registered at PROSPERO International prospective register of systematic reviews under registration no. CRD42015015337.
Appendix
Available only for authorised users
Literature
1.
go back to reference José RJ, Periselneris JN, Brown JS. Community-acquired pneumonia. Curr Opin Pulm Med. 2015;21:212–8.CrossRef José RJ, Periselneris JN, Brown JS. Community-acquired pneumonia. Curr Opin Pulm Med. 2015;21:212–8.CrossRef
2.
go back to reference Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG, Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.CrossRef Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG, Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.CrossRef
3.
go back to reference Wunderink RG, Waterer GW. Clinical practice. Community-acquired pneumonia. N Engl J Med. 2014;370:543–51.CrossRef Wunderink RG, Waterer GW. Clinical practice. Community-acquired pneumonia. N Engl J Med. 2014;370:543–51.CrossRef
4.
go back to reference Adamuz J, Viasus D, Jiménez-Martínez E, Isla P, Garcia-Vidal C, Dorca J, Carratalà J. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. J Inf Secur. 2014;68:534–41. Adamuz J, Viasus D, Jiménez-Martínez E, Isla P, Garcia-Vidal C, Dorca J, Carratalà J. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. J Inf Secur. 2014;68:534–41.
5.
go back to reference Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121:1486–92.CrossRef Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121:1486–92.CrossRef
6.
go back to reference Fukuyama H, Yamashiro S, Kinjo K, Tamaki H, Kishaba T. Validation of sputum gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study. BMC Infect Dis. 2014;14:534.CrossRef Fukuyama H, Yamashiro S, Kinjo K, Tamaki H, Kishaba T. Validation of sputum gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study. BMC Infect Dis. 2014;14:534.CrossRef
7.
go back to reference Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections. 2006. Guidelines for the management of community acquired pneumonia in adults, revised edition Respirology 11:S79–133. Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections. 2006. Guidelines for the management of community acquired pneumonia in adults, revised edition Respirology 11:S79–133.
8.
go back to reference Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. 2011. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 17:E1–E59. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. 2011. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 17:E1–E59.
9.
go back to reference Reed WW, Byrd GS, Gates RH Jr, Howard RS, Weaver MJ. Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis. West J Med. 1996;165:197–204.PubMedPubMedCentral Reed WW, Byrd GS, Gates RH Jr, Howard RS, Weaver MJ. Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis. West J Med. 1996;165:197–204.PubMedPubMedCentral
10.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008e12.CrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008e12.CrossRef
11.
go back to reference Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.CrossRef Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.CrossRef
12.
go back to reference Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168–9.CrossRef Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168–9.CrossRef
13.
go back to reference Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–43.CrossRef Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–43.CrossRef
14.
go back to reference Merrill CW, Gwaltney JM Jr, Hendley JW, Sande MA. Rapid identification of pneumococci. Gram stain vs. the quellung reaction. N Engl J Med. 1973;288:510–2.CrossRef Merrill CW, Gwaltney JM Jr, Hendley JW, Sande MA. Rapid identification of pneumococci. Gram stain vs. the quellung reaction. N Engl J Med. 1973;288:510–2.CrossRef
15.
go back to reference Thorsteinsson SB, Musher DM, Fagan T. The diagnostic value of sputum culture in acute pneumonia. JAMA. 1975;233:894–5.CrossRef Thorsteinsson SB, Musher DM, Fagan T. The diagnostic value of sputum culture in acute pneumonia. JAMA. 1975;233:894–5.CrossRef
16.
go back to reference Rein MF, Gwaltney JM Jr, O'Brien WM, Jennings RH, Mandell GL. Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA. 1978;239:2671–3.CrossRef Rein MF, Gwaltney JM Jr, O'Brien WM, Jennings RH, Mandell GL. Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA. 1978;239:2671–3.CrossRef
17.
go back to reference Boerner DF, Zwadyk P. The value of the sputum gram's stain in community-acquired pneumonia. JAMA. 1982;247:642–5.CrossRef Boerner DF, Zwadyk P. The value of the sputum gram's stain in community-acquired pneumonia. JAMA. 1982;247:642–5.CrossRef
18.
go back to reference Dans PE, Charache P, Fahey M, Otter SE. Management of pneumonia in the prospective payment era. Arch Intern Med. 1984;144:1392–7.CrossRef Dans PE, Charache P, Fahey M, Otter SE. Management of pneumonia in the prospective payment era. Arch Intern Med. 1984;144:1392–7.CrossRef
19.
go back to reference Research Committee of the British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. QJM. 1987;62:195–220.CrossRef Research Committee of the British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. QJM. 1987;62:195–220.CrossRef
20.
go back to reference Lentino JR, Lucks DA. Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol. 1987;25:758–62.PubMedPubMedCentral Lentino JR, Lucks DA. Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol. 1987;25:758–62.PubMedPubMedCentral
21.
go back to reference Gleckman R, DeVita J, Hibert D, Pelletier C, Martin R. Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol. 1988;26:846–9.PubMedPubMedCentral Gleckman R, DeVita J, Hibert D, Pelletier C, Martin R. Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol. 1988;26:846–9.PubMedPubMedCentral
22.
go back to reference Xiaoping Z, Kuen D, Yaoqing Y, Wentong L. Rapid identification of pneumococcal antigens in sputa in patients with community-acquired pneumonia by coagglutination. Med Microbiol Immunol. 1988;177:333–8.CrossRef Xiaoping Z, Kuen D, Yaoqing Y, Wentong L. Rapid identification of pneumococcal antigens in sputa in patients with community-acquired pneumonia by coagglutination. Med Microbiol Immunol. 1988;177:333–8.CrossRef
23.
go back to reference Lim I, Shaw DR, Stanley DP, Lumb R, McLennan G. A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust. 1989;151:87–91.PubMed Lim I, Shaw DR, Stanley DP, Lumb R, McLennan G. A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust. 1989;151:87–91.PubMed
24.
go back to reference Fine MJ, Orloff JJ, Rihs JD, Vickers RM, Kominos S, Kapoor WN, Arena VC, Yu VL. Evaluation of housestaff physicians' preparation and interpretation of sputum gram stains for community-acquired pneumonia. J Gen Intern Med. 1991;6:189–98.CrossRef Fine MJ, Orloff JJ, Rihs JD, Vickers RM, Kominos S, Kapoor WN, Arena VC, Yu VL. Evaluation of housestaff physicians' preparation and interpretation of sputum gram stains for community-acquired pneumonia. J Gen Intern Med. 1991;6:189–98.CrossRef
25.
go back to reference Belliveau P, Hickingbotham N, Maderazo EG, Mazens-Sullivan M, Robinson A. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia. Pharmacotherapy. 1993;13:396–401.PubMed Belliveau P, Hickingbotham N, Maderazo EG, Mazens-Sullivan M, Robinson A. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia. Pharmacotherapy. 1993;13:396–401.PubMed
26.
go back to reference Bohte R, Hermans J, van den Broek PJ. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1996;15:201–5.CrossRef Bohte R, Hermans J, van den Broek PJ. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1996;15:201–5.CrossRef
27.
go back to reference Rosón B, Carratalà J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:869–74.CrossRef Rosón B, Carratalà J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:869–74.CrossRef
28.
go back to reference Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2004;39:165–9.CrossRef Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2004;39:165–9.CrossRef
29.
go back to reference Miyashita N, Shimizu H, Ouchi K, Kawasaki K, Kawai Y, Obase Y, Kobashi Y, Oka M. Assessment of the usefulness of sputum gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit. 2008;14:CR171–6.PubMed Miyashita N, Shimizu H, Ouchi K, Kawasaki K, Kawai Y, Obase Y, Kobashi Y, Oka M. Assessment of the usefulness of sputum gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit. 2008;14:CR171–6.PubMed
30.
go back to reference Anevlavis S, Petroglou N, Tzavaras A, Maltezos E, Pneumatikos I, Froudarakis M, Anevlavis E, Bouros D. A prospective study of the diagnostic utility of sputum gram stain in pneumonia. J Inf Secur. 2009;59:83–9. Anevlavis S, Petroglou N, Tzavaras A, Maltezos E, Pneumatikos I, Froudarakis M, Anevlavis E, Bouros D. A prospective study of the diagnostic utility of sputum gram stain in pneumonia. J Inf Secur. 2009;59:83–9.
31.
go back to reference Ferré C, Llopis F, Jacob J, Juan A, Palom X, Bardés-Robles I, Salazar-Soler A. Evaluación de la utilidad de la tinción de Gram del esputo para el manejo de la neumonía en urgencias. Emergencias. 2011;23:108–11. Ferré C, Llopis F, Jacob J, Juan A, Palom X, Bardés-Robles I, Salazar-Soler A. Evaluación de la utilidad de la tinción de Gram del esputo para el manejo de la neumonía en urgencias. Emergencias. 2011;23:108–11.
32.
go back to reference O'Horo JC, Thompson D, Safdar N. Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis. 2012;55:551–61.CrossRef O'Horo JC, Thompson D, Safdar N. Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis. 2012;55:551–61.CrossRef
33.
go back to reference Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, Sakr Y. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 2008;12:R56.CrossRef Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, Sakr Y. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 2008;12:R56.CrossRef
34.
go back to reference Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, Mensa J, Torres A. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66:340–6.CrossRef Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, Mensa J, Torres A. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66:340–6.CrossRef
35.
go back to reference Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, Manresa F, Gudiol F, Carratalà J. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore). 2011;90:110–8.CrossRef Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, Manresa F, Gudiol F, Carratalà J. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore). 2011;90:110–8.CrossRef
36.
go back to reference Lagerström F, Fredlund H, Holmberg H. Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care. Scand J Prim Health Care. 2004;22:83–6.CrossRef Lagerström F, Fredlund H, Holmberg H. Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care. Scand J Prim Health Care. 2004;22:83–6.CrossRef
37.
go back to reference García-Vázquez E, Marcos MA, Mensa J, de Roux A, Puig J, Font C, Francisco G, Torres A. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004;164:1807–11.CrossRef García-Vázquez E, Marcos MA, Mensa J, de Roux A, Puig J, Font C, Francisco G, Torres A. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004;164:1807–11.CrossRef
38.
go back to reference Yang S, Lin S, Khalil A, Gaydos C, Nuemberger E, Juan G, Hardick J, Bartlett JG, Auwaerter PG, Rothman RE. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol. 2005;43:3221–6.CrossRef Yang S, Lin S, Khalil A, Gaydos C, Nuemberger E, Juan G, Hardick J, Bartlett JG, Auwaerter PG, Rothman RE. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol. 2005;43:3221–6.CrossRef
39.
go back to reference Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;60:255–61.CrossRef Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;60:255–61.CrossRef
40.
go back to reference Murdoch DR, Anderson TP, Beynon KA, Chua A, Fleming AM, Laing RT, Town GI, Mills GD, Chambers ST, Jennings LC. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol. 2003;41:63–6.CrossRef Murdoch DR, Anderson TP, Beynon KA, Chua A, Fleming AM, Laing RT, Town GI, Mills GD, Chambers ST, Jennings LC. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol. 2003;41:63–6.CrossRef
41.
go back to reference Kais M, Spindler C, Kalin M, Ortqvist A, Giske CG. Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR. Diagn Microbiol Infect Dis. 2006;55:169–78.CrossRef Kais M, Spindler C, Kalin M, Ortqvist A, Giske CG. Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR. Diagn Microbiol Infect Dis. 2006;55:169–78.CrossRef
42.
go back to reference Stralin K, Herrmann B, Abdeldaim G, Olcen P, Holmberg H, Molling P. Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumonia. J Clin Microbiol. 2014;52:83–9.CrossRef Stralin K, Herrmann B, Abdeldaim G, Olcen P, Holmberg H, Molling P. Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumonia. J Clin Microbiol. 2014;52:83–9.CrossRef
43.
go back to reference Kakiuchi S, Suzuki M, Dhoubhadel BG, Furumoto A, Ito H, Matsuki K, Tsuchihashi Y, Asoh N, Yasunami M, Ariyoshi K, Morimoto K. Accuracy of high-throughput Nanofluidic PCR-based pneumococcal serotyping and quantification assays using sputum samples for diagnosing vaccine serotype pneumococcal pneumonia: analyses by composite diagnostic standards and Bayesian latent class models. J Clin Microbiol. 2018;56:e01874–17.CrossRef Kakiuchi S, Suzuki M, Dhoubhadel BG, Furumoto A, Ito H, Matsuki K, Tsuchihashi Y, Asoh N, Yasunami M, Ariyoshi K, Morimoto K. Accuracy of high-throughput Nanofluidic PCR-based pneumococcal serotyping and quantification assays using sputum samples for diagnosing vaccine serotype pneumococcal pneumonia: analyses by composite diagnostic standards and Bayesian latent class models. J Clin Microbiol. 2018;56:e01874–17.CrossRef
44.
go back to reference Manali E, Papadopoulos A, Tsiodras S, Polychronopoulos V, Giamarellou H, Kanellakopoulou K. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques. Scand J Infect Dis. 2008;40:286–92.CrossRef Manali E, Papadopoulos A, Tsiodras S, Polychronopoulos V, Giamarellou H, Kanellakopoulou K. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques. Scand J Infect Dis. 2008;40:286–92.CrossRef
45.
go back to reference Oosterheert JJ, Bonten MJ, Buskens E, Schneider MM, Hoepelman IM. Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing. J Clin Microbiol. 2003;41:4708–13.CrossRef Oosterheert JJ, Bonten MJ, Buskens E, Schneider MM, Hoepelman IM. Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing. J Clin Microbiol. 2003;41:4708–13.CrossRef
46.
go back to reference van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, Boersma WG. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60:672–8.CrossRef van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, Boersma WG. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60:672–8.CrossRef
Metadata
Title
Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis
Authors
Gaspar Del Rio-Pertuz
Juan F. Gutiérrez
Abel J. Triana
Jorge L. Molinares
Andrea B. Robledo-Solano
José L. Meza
Orlando M. Ariza-Bolívar
Jorge Acosta-Reyes
Argenis Garavito
Diego Viasus
Jordi Carratalà
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4048-6

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine